Edward Stelmakh

Chief Financial & Strategy Officer (principal financial and accounting officer), OptimizeRx Corporation

Leaving, effective January 1, 2027. First published here October 28, 2026; built from records as of October 28, 2026.

Edward Stelmakh is leaving the chief financial officer seat at OptimizeRx Corporation: the company's filing of August 12, 2026 gives January 1, 2027 as the effective date.² The same filing names Andrew D’Silva as the successor.²

Seats

The seat in the record

Company	Title as filed	Standing	Filings
OptimizeRx Corporation (OPRX) Services-Business Services, NEC	Chief Financial & Strategy Officer (principal financial and accounting officer)	Leaving, effective January 1, 2027	2

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

January 1, 2027takes effect
OptimizeRx Corporation named Andrew D’Silva to succeed Edward Stelmakh, effective January 1, 2027. Profile of Andrew D’Silva.
Edward Stelmakh will step down as Chief Financial & Strategy Officer effective December 31, 2026.
[2] Filing by OptimizeRx Corporation, filed with the SEC on August 12, 2026. Read the filing. The record at CFO Tribune.
March 12, 202610-K filed
Edward Stelmakh signed the annual report of OptimizeRx Corp on Form 10-K as Chief Financial & Strategy Officer (principal financial and accounting officer), filed March 12, 2026.
/s/ Edward Stelmakh Chief Financial & Strategy Officer (principal financial and accounting officer)
[1] Annual report on Form 10-K by OptimizeRx Corp, filed with the SEC on March 12, 2026. Read the filing. The record at CFO Tribune.

Sources

Annual report on Form 10-K, OptimizeRx Corp. U.S. Securities and Exchange Commission, EDGAR, filed March 12, 2026. sec.gov; record.
Current report filed with the SEC, OptimizeRx Corporation. U.S. Securities and Exchange Commission, EDGAR, filed August 12, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Edward Stelmakh wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.